Bloomberg Business

Biogen Data Suggest ALS Drug Has Treatment Effect, FDA Staff Say

Biogen Inc.’s studies of its drug for a rare form of amyotrophic lateral sclerosis suggest the drug has a “treatment effect,” the Food and Drug Administration’s staff said in documents released ahead of a meeting out of outside advisers this week.